Peripheral lymphocyte CD39 expression in NSCLC patients was limited to B cells (CD19+), while low levels of CD39 expression were observed among CD4+ T cells, CD8+ T cells and NK cells (CD56+) (figure 1B). Here, CD19 is linked to non-small cell lung carcinoma.